Searched for
FDA APPROVED DRUGS
17-year-old Connecticut student found 2 FDA-approved drugs that could help fight Alzheimer’s: How his surprising discovery worksA 17-year-old Connecticut student, Leon Wang, identified two FDA-approved lung-scarring drugs that reduced Alzheimer’s-linked cellular dama...- Symbiotec Pharmalab IPO Day 2: GMP signals 34% upside — Should you subscribe?Symbiotec Pharmalab's IPO saw robust investor demand, with the issue subscribed 1.85 times. The company aims to raise Rs 1,757 crore throug...
- Symbiotec Pharmalab’s Rs 1,757 crore IPO opens with GMP hinting at 41% upside. Should you bid?Symbiotec Pharmalab IPO GMP: Symbiotec Pharmalab’s Rs 1,757 crore IPO opened August 24, with a Rs 938–988 price band and 41% grey-market pr...
- Indian pharma has little reason to fear TrumpUS tariff threats on Indian generic drugs face significant obstacles. These duties could increase American healthcare costs and potentially...
- Can Symbiotec Pharmalab IPO deliver long-term growth for high-risk investors?Symbiotec Pharmalab plans a ₹150 crore IPO to repay debt and expand operations. The company holds a global leadership position in corticost...
- Stocks in news: Reliance Industries, Bank of Baroda, Power Grid, NATCO Pharma and JSW InfraIndian equity markets closed largely unchanged on Friday, August 21, after a volatile trading session. Several companies, including Relianc...
- 'Tukaram Mundhe approved eatery': Harsh Goenka says forget Michelin stars as Maharashtra FDA chief’s strict food safety checks take social media by stormTukaram Mundhe, Maharashtra's FDA commissioner, has been making waves on social media with his strict approach to food safety. His inspecti...
- Symbiotec Pharmalab gets Rs 526 crore anchor backing ahead of IPO; Citi Group, Singularity among investorsSymbiotec Pharmalab has raised Rs 526.20 crore from anchor investors ahead of its Rs 1,757 crore IPO opening August 24. The pharmaceutical ...
- Natalie Harp who has a ‘very unhealthy’ relationship with Trump reportedly worked without security clearance at White House for over a yearNatalie Harp reportedly worked over a year without required security clearance. Concerns arose due to her close access and information filt...
- 'Major impact in 8-10 days': Maharashtra FDA chief warns of strict action over rules violations by eateries near educational institutionsMaharashtra Food and Drug Administration (FDA) Commissioner Tukaram Mundhe on Tuesday said strict action would be taken against violations ...
- When there's no seat, make one: Natalie Harp's ride-or-die routine with TrumpNatalie Harp has become a key aide to Donald Trump since joining his staff. She now manages communications and drafts his social media post...
- Who is Natalie Harp who wrote 'you're all that matters to me' for Trump: US President’s ‘human printer’ at the centre of a new sexism and relationship rowNatalie Harp, an executive assistant, faces political controversy over her close access to Donald Trump. Senator Jon Ossoff's remarks ignit...
- Symbiotec Pharmalab sets price band for Rs 1,757 crore IPO, to open on August 24Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 1...
- Biocon shares rise 2% after USFDA approval for Yesintek single-dose prefilled autoinjectorBiocon shares rose after its US subsidiary received supplemental FDA approval for Yesintek single-dose prefilled autoinjectors in two stren...
- EyePoint's drug for age-related eye disease fails late-stage trial, shares tank 70%EyePoint's experimental drug Duravyu failed a late-stage trial for a serious eye disease. The company's shares dropped significantly after ...
- Lupin gets USFDA nod for generic tablets to treat excessive daytime sleepinessPharma major Lupin Ltd announced receiving final USFDA approval for its generic Pitolisant tablets. These tablets are indicated for treatin...
- US stocks: Capricor shares 77% soar as potential FDA lifeline revives Duchenne drug hopesCapricor Therapeutics shares surged significantly after the FDA agreed to review new drug data. The company had faced setbacks last month r...
- Trump’s vaccine overhaul could bring more shots, higher costs for US familiesPresident Donald Trump's vaccine plan faces significant financial and logistical hurdles. Drugmakers must develop new manufacturing process...
- Maharashtra FDA cracks down on Ayurvedic drug makers, cancels 10 licencesMaharashtra FDA has launched a statewide crackdown on Ayurvedic drug manufacturers. Inspections revealed serious violations of manufacturin...
- Karnataka tightens food safety rules as hotel inspections uncover tonnes of unsafe foodKarnataka has issued a detailed food-safety advisory for hotels, restaurants, caterers and food businesses amid intensified inspections acr...
Load More
